Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
Cash from Financing Activities
Beijing Hotgen Biotech Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
Cash from Financing Activities
-¥485m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-173%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Financing Activities
¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Financing Activities
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Financing Activities
-¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Cash from Financing Activities
¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Hotgen Biotech Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-485m
CNY
Based on the financial report for Dec 31, 2022, Beijing Hotgen Biotech Co Ltd's Cash from Financing Activities amounts to -485m CNY.
What is Beijing Hotgen Biotech Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-173%
Over the last year, the Cash from Financing Activities growth was -410%.